Jump to content

syneos Health

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Shahid1618 (talk | contribs) at 02:02, 25 April 2016 (Campbell Alliance is now known as Inventiv Health consulting, so consolidating these entries in the list). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

InVentiv Health
Company typePublic
IndustryPharmaceutical
Biotechnology
Medical Device
Clinical Research
Founded1999
HeadquartersBurlington, Massachusetts, United States of America
Key people
Mike Bell (Chairman and CEO)
Productsbiopharmaceutical product development
regulatory consulting
clinical trials management
advanced eClinical technology solutions
Number of employees
14,000
Websitewww.inventivhealth.com

inVentiv Health Incorporated is an American multinational, and one of the largest contract research organization (CRO), based in Burlington, Massachusetts.[1][2] It is a wholly owned subsidiary of inVentiv Holdings Group based in Somerset, New Jersey. The company provides services to the pharmaceutical, biotechnology and medical device industries, including consulting, clinical studies and market launch.[3] The global CRO constitutes the inVentiv Health Clinical, the inVentiv Health Commercial, the inVentiv Health Consulting, and the Adheris Health.[4] The company is spread across U.S., Europe, Japan, China, Korea and India. The company offers customized patient centric solutions through its EMBARX technology.[clarification needed][5][6]

References

  1. ^ "Advaxis Selects inVentiv Health Clinical To Conduct Clinical Trials Of Immunotherapy Candidates" (Press release). inVentiv Health Clinical. 29 May 2014. Archived from the original on 12 August 2014 – via Yahoo Finance via PR NewsWire. {{cite press release}}: Unknown parameter |dead-url= ignored (|url-status= suggested) (help)[self-published source]
  2. ^ "inVentiv Health To Acquire Leading Management Consulting Firm, Campbell Alliance, and Global CRO Organization, i3" (Press release). inVentiv Health. 21 January 2011. Retrieved 2015-08-03 – via FierceBiotech.[self-published source]
  3. ^ "inVentiv Clinical Trial Recruitment Solutions Shares Insights On The Use Of Behavioral Science To Improve Patient Recruitment And Retention" (Press release). inVentiv Health. 19 May 2014. Archived from the original on 27 July 2014. Retrieved 2015-08-03 – via Reuters via PR NewsWire. {{cite press release}}: Unknown parameter |dead-url= ignored (|url-status= suggested) (help)[self-published source]
  4. ^ "Risk Assessment: Laying the Foundation for RBM". XTalks. Honeycomb Worldwide. 14 November 2013. Retrieved 2015-08-03.
  5. ^ "inVentiv Health Launches EMBARX™, an Integrated Solution for Market Access Challenges" (Press release). inVentiv Health. 8 April 2012. Retrieved 2015-08-03.[self-published source]
  6. ^ "Corporate Fact Sheet" (PDF). inVentiv Health. Archived from the original (PDF) on 29 July 2014. {{cite web}}: Unknown parameter |dead-url= ignored (|url-status= suggested) (help)[self-published source]

Further reading

Retrieved from "https://en.wikipedia.org/w/index.php?title=Syneos_Health&oldid=716986214"